Breaking Finance News

Quest Diagnostics Inc (NYSE:DGX) target price raised to $93.00, reported today by Zacks Investment Research

Quest Diagnostics Inc (NYSE:DGX) had its target price raised to $93.00 by Zacks Investment Research in a report issued Wednesday September 21, 2016. The updated stock price target implies a possible upside of 0.11% based on the company's previous closing price.

Previously on Friday September 09, 2016, Citigroup Inc. reported on Quest Diagnostics Inc (NYSE:DGX) increased the target price from $0.00 to $86.00. At the time, this indicated a possible upside of 0.02%.

Just yesterday Quest Diagnostics Inc (NYSE:DGX) traded 2.12% higher at $83.80. Quest Diagnostics Inc’s 50-day moving average is $84.08 and its 200-day moving average is $78.51. The last closing price is up 8.08% from the 200-day moving average, compared to the Standard & Poor's 500 Index which has decreased -0.01% over the same time period. 1,204,543 shares of DGX traded hands, up from an average trading volume of 1,196,330

Recent Performance Chart

Quest Diagnostics Inc (NYSE:DGX)

Quest Diagnostics Inc has 52 week low of $59.66 and a 52 week high of $86.85 with a PE ratio of 14.81 and has a market capitalization of $0.

In addition to Zacks Investment Research reporting its stock price target, a total of 16 brokers have issued a research note on the company. The average stock price target is $74.13 with 1 broker rating the stock a strong buy, 2 brokers rating the stock a buy, 17 brokers rating the stock a hold, 2 brokers rating the stock a underperform, and finally 0 brokers rating the stock a sell.

Brief Synopsis On Quest Diagnostics Inc (NYSE:DGX)

Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company operates through two businesses: Diagnostic Information Services and Diagnostic Solutions. The Company's Diagnostic Information Services business develops and delivers diagnostic testing information and services to patients, physicians, health plans, hospitals, accountable care organizations (ACOs), integrated delivery networks (IDNs), other commercial laboratories, employers and others. The Company's Diagnostic Solutions offers a range of solutions for insurers and healthcare providers. The Company provides risk assessment services for the life insurance industry. In addition, the Company offers healthcare organizations and clinicians' health information technology solutions and diagnostic products. ExamOne provides risk assessment services to the life insurance industry in North America. ChartMaxx is the Company's enterprise content management system for hospitals.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *